Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

VIVUS Earnings: Here’s Why Investors are Not Excited Now
Wall St. Cheat Sheet
Tuesday, February 26, 2013 - 10:33am
tags:
earnings, Vivus
Dynavax: The Path Forward
Seeking Alpha
Tuesday, February 26, 2013 - 10:32am
tags:
Dynavax, Heplisav, hepatitis B
Atherosclerosis and the New Gold Standard
Yahoo/Accesswired
Tuesday, February 26, 2013 - 10:29am
tags:
atherosclerosis, statins, Pfizer, Merck, AstraZeneca, AtheroNova, AHRO-001
United Therapeutics 4Q profit jumps 93 percent
Yahoo/AP
Tuesday, February 26, 2013 - 10:27am
tags:
earnings, United Therapeutics
Amarin submits sNDA for Vascepa
The Fly on the Wall
Tuesday, February 26, 2013 - 10:15am
tags:
Amarin, Vascepa
Endo To Become The Next Valeant - Or Part Of Valeant
Seeking Alpha
Tuesday, February 26, 2013 - 10:14am
tags:
Valeant Pharmaceuticals, Endo Health Solutions
The Fight Over This Biotech's Cash
Motley Fool
Tuesday, February 26, 2013 - 10:13am
tags:
Elan, Royalty Pharma
Impax Laboratories Earnings:Everything You Must Know Now
Wall St. Cheat Sheet
Tuesday, February 26, 2013 - 10:11am
tags:
earnings, Impax Laboratories
Endocyte's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, February 26, 2013 - 10:09am
tags:
earnings, Endocyte
Battle of the Pharma Dividends: Bristol vs. Lilly
Motley Fool
Tuesday, February 26, 2013 - 10:08am
tags:
dividends, Eli Lilly, Bristol-Myers Squibb
Is Abbott's Universal Microbe Detector a Big Deal?
Motley Fool
Tuesday, February 26, 2013 - 10:07am
tags:
Abbott Laboratories, PLEX-ID
Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk
Bloomberg
Tuesday, February 26, 2013 - 10:04am
tags:
Merck, diabetes, Bristol-Myers Squibb, pancreatitis, Januvia, Byetta
FDA approves Bayer cancer pill for hard-to-treat tumors of the intestinal tract
Yahoo/AP
Tuesday, February 26, 2013 - 10:03am
tags:
FDA, Bayer, Stivarga, intestinal cancer
India's Ranbaxy surprises with Q4 loss, sees modest sales growth in 2013
Reuters
Tuesday, February 26, 2013 - 10:00am
tags:
earnings, Ranbaxy
J&J Expert Grilled on Calculation of Hip Placement Device
Bloomberg
Tuesday, February 26, 2013 - 9:59am
tags:
JNJ, hip implants
J&J Told to Pay $3.35 Million in First Vaginal Mesh Case
Bloomberg
Tuesday, February 26, 2013 - 9:59am
tags:
JNJ, vaginal mesh
Obama And Access To Federally Funded Research
Phamalot
Monday, February 25, 2013 - 10:34am
tags:
R&D, federally-funded research
Royalty Pharma proposes $6.6 bln bid for Elan
Reuters
Monday, February 25, 2013 - 10:30am
tags:
M&A, Royalty Pharma, Elan
Dendreon posts 4th-quarter loss versus year-ago profit
Reuters
Monday, February 25, 2013 - 10:19am
tags:
earnings, Dendreon
SPPI Beats in 4Q on Higher Sales
Yahoo/Zacks
Monday, February 25, 2013 - 10:17am
tags:
earnings, Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.